Simris Biologics identifies and develops applications for novel, natural biologics sourced from cyanobacteria and microalgae. The company develops technology platforms based on these compounds and partners with customers to create final products.

Simris Biologics

Lumen is a biotechnology company focused on synthetic biology, protein design, and immunology to create a portfolio of biologic therapies and scientific discoveries.

Lumen

Living Ink Technologies produces black pigments and printing inks using a renewable process that transforms biomass waste into carbon-negative products.

Living Ink Technologies

Algenuity operates an integrated biotechnology and microbial fermentation platform to deliver neutral-tasting, nutritious plant-based protein ingredients derived from Chlorella. The company focuses on addressing challenges in taste, smell, and color to enhance the use of Chlorella in food and beverage markets.

Algenuity

Simris Biologics is focused on identifying and developing applications for novel, natural biologics sourced from cyanobacteria and microalgae. The company develops technology platforms based on these compounds and collaborates with customers under license agreements to create final products.

Metric
Company Name	Simris Biologics	Lumen	Living Ink Technologies	Algenuity
Symbol
MSH ID	COM:SIMRISBIOLOGICS	BIO:LUMEN	CO:LIVINGINK	COM:ALGENUITY
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Basic Materials & Materials	Consumer Goods
Industry	Biotechnology	Biotechnology	Specialty Chemicals	Food Ingredients
Country	SE	US	US	GB
Stage
Employee Count		68	11
Website	simrisbiologics.com	lumen.bio	livingink.co	algenuity.com
LinkedIn		lumen-bioscience	living-ink-technologies	algenuity
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	88
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SIMR

COM:SIMRISBIOLOGICS

Simris Biologics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue